Article
Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.
Breast cancer research and treatment - 1 Jun 2013
Roca Lise, Diéras Véronique, Roché Henri, Lappartient Emmanuelle, Kerbrat Pierre, Cany Laurent, Chieze Stéphanie, Canon Jean-Luc, Spielmann Marc, Penault-Llorca Frédérique, Martin Anne-Laure, Mesleard Christel, Lemonnier Jérôme, de Cremoux Patricia
Abstract excerpt
The purpose of this study was to investigate, in the context of a prospective node-positive-breast cancer trial HER2 containing-regimen (UNICANCER-PACS 04 trial), the predictive value of HER2, FCGRIIA, and FCGRIIIA gene polymorphisms for cardiac toxicity and efficacy of trastuzumab. We analyzed H...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.